 |
Date Announced: 11 Dec 2017
Addition to IDEX health and science division seen as strong fit with existing optics expertise.
LAKE FOREST, Ill.--(BUSINESS WIRE)--Dec. 11, 2017-- IDEX Corporation (NYSE:IEX) announced today the acquisition of thinXXS Microtechnology AG; a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets.
Located in Zweibrücken, Germany, thinXXS will operate within IDEX Health & Science LLC, part of IDEX’s Health and Science Technologies (HST) segment.
Commenting on the acquisition, IDEX Chairman and Chief Executive Officer Andy Silvernail stated, “thinXXS represents our second acquisition in this space, and with the addition of their advanced technology, our combination makes IDEX Health and Science the market leader in microfluidic technology. thinXXS’ product portfolio is a fantastic fit with IDEX’s core optics and scientific fluidics products and technologies that serve our life science customers. We look forward to thinXXS joining IDEX and we believe the transaction will accelerate our growth prospects in the life science, veterinary and point of care markets.”
Source: IDEX
E-mail: via web site
Web Site: www.idexcorp.com
| © 2024 SPIE Europe |
|
